SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-019445
Filing Date
2014-03-31
Accepted
2014-03-31 16:22:48
Documents
5
Period of Report
2014-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v373326_8k.htm 8-K 37821
2 EXHIBIT 10.1 v373326_ex10-1.htm EX-10.1 23967
3 EXHIBIT 10.2 v373326_ex10-2.htm EX-10.2 12996
4 EXHIBIT 99.1 v373326_ex99-1.htm EX-99.1 10285
5 GRAPHIC image_001.jpg GRAPHIC 2121
  Complete submission text file 0001144204-14-019445.txt   89518
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32715 | Film No.: 14730352
SIC: 2835 In Vitro & In Vivo Diagnostic Substances